[HTML][HTML] Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions
D Borsook, L Becerra, R Hargreaves - Discovery medicine, 2011 - discoverymedicine.com
Chronic pain remains a significant clinical problem that has few effective therapies. Currently
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions.
D Borsook, L Becerra, R Hargreaves - Discovery Medicine, 2011 - europepmc.org
Chronic pain remains a significant clinical problem that has few effective therapies. Currently
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
[HTML][HTML] Biomarkers for Chronic Pain and Analgesia. Part 1: The Need, Reality, Challenges, and Solutions
D Borsook, L Becerra, R Hargreaves - Discovery Medicine, 2011 - discoverymedicine.com
Chronic pain remains a significant clinical problem that has few effective therapies. Currently
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions
D Borsook, L Becerra… - Discovery medicine, 2011 - pubmed.ncbi.nlm.nih.gov
Chronic pain remains a significant clinical problem that has few effective therapies. Currently
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …
the success rate for treating chronic pain with analgesics is around 30%. Both treatment and …